|This Slide: #98 of 100|
Slide #98. Auxilium Pharmaceuticals — Actient Holdings LLC
Auxilium Pharmaceuticals (AUXL)
Actient Holdings LLC
GTCR, a leading private equity firm, announced today it has sold its portfolio company, Actient Holdings LLC ("Actient"), to Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL,Auxilium), a specialty biopharmaceutical company. Headquartered in Lake Forest, Illinois, Actient is a specialty pharmaceutical company focused on developing, acquiring and marketing products that significantly improve patient outcomes.
Auxilium Pharmaceuticals is a biopharmaceutical company with a focus on developing and commercializing products for specialist audiences. Co. has a range of first- and second-line products across multiple indications, including men's healthcare, orthopedics, dermatology and other therapeutic areas. Among other products in the U.S., Co. markets Testim® (testosterone gel) for the topical treatment of hypogonadism; TESTOPEL® (testosterone pellets) a long-acting implantable testosterone replacement therapy product; STENDRA™ (avanafil), an oral erectile dysfunction (ED) therapy; as well as Edex® (alprostadil for injection), an injectable treatment for ED.
Open the AUXL Page at The Online Investor »
Free AUXL Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite